CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse® technology in patients with s...

Full description

Saved in:
Bibliographic Details
Main Authors: Garcia-Valdecasas Gayo Sonsoles, Ruiz-Alvarez Maria Jesus, Gonzalez-Gay Daniel, Ramos-Corral Raquel, Marquez-Lietor Eva, Del Amo Nazaret, Plata Maria del Carmen, Guillén-Santos Raquel, Arribas Ignacio, Cava-Valenciano Fernando
Format: article
Language:EN
ES
Published: De Gruyter 2020
Subjects:
bladder cancer
cutoff
cyfra 21-1
lung cancer
non-small cell lung cancer (nsclc)
prognosis
tumor marker
Medical technology
R855-855.5
Online Access:https://doaj.org/article/982c08d81cda467fa39bf2018dbdc8d1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/982c08d81cda467fa39bf2018dbdc8d1

Similar Items